期刊
CANCER GENE THERAPY
卷 15, 期 3, 页码 133-139出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.cgt.7701103
关键词
resveratrol; adenovirus; TNFerade; SIRT1; TNF-alpha
类别
资金
- NCI NIH HHS [CA111423] Funding Source: Medline
We report the anticarcinogenic, anti-aging polyphenol resveratrol activates the radio- and chemo-inducible cancer gene therapy vector Ad. Egr.TNF, a replication-deficient adenovirus that expresses human tumor necrosis factor a (TNF-alpha) under control of the Egr-1 promoter. Like ionizing radiation or chemotherapeutic agents previously shown to activate Ad. Egr. TNF, resveratrol also induces Egr-1 expression from its chromosomal locus with a possible role for Egr-1 promoter CC(A+T) richGG sequences in the expression of TNF-alpha. Resveratrol induction of TNF-alpha in Ad. Egr. TNF-infected tumor xenografts demonstrated antitumor response in human and rat tumor models comparable to that of radio- or chemotherapy-induced TNF-alpha. Although sirtuins are known targets of resveratrol, in vitro inhibition of SIRT1 activity did not abrogate resveratrol induction of Egr-1 expression. This suggests that SIRT1 is not essential to mediate resveratrol induction of Egr-1. Nevertheless, control of transgene expression via resveratrol activation of Egr-1 may extend use of Ad. Egr. TNF to patients intolerant of radiation or cytotoxic therapy and offer a novel tool for development of other inducible gene therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据